Massively parallel sequencing of micro-manipulated cells targeting a comprehensive panel of disease-causing genes: A comparative evaluation of upstream whole-genome amplification methods

Single Gene Disorders (SGD) are still routinely diagnosed using PCR-based assays that need to be developed and validated for each individual disease-specific gene fragment. The TruSight One sequencing panel currently covers 12 Mb of genomic content, including 4813 genes associated with a clinical ph...

Descripción completa

Detalles Bibliográficos
Autores principales: Deleye, Lieselot, Gansemans, Yannick, De Coninck, Dieter, Van Nieuwerburgh, Filip, Deforce, Dieter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919401/
https://www.ncbi.nlm.nih.gov/pubmed/29698522
http://dx.doi.org/10.1371/journal.pone.0196334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919401/
https://www.ncbi.nlm.nih.gov/pubmed/29698522
http://dx.doi.org/10.1371/journal.pone.0196334

Ejemplares similares